Source: Eur Respir J 2016; 48: 962
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Janice M. Leung, John Mayo, Wan Tan, C. Martin Tammemagi, Geoffrey Liu, Stuart Peacock, Frances A. Shepherd, John Goffin, Glenwood Goss, Garth Nicholas, Alain Tremblay, Michael Johnston, Simon Martel, Francis Laberge, Rick Bhatia, Heidi Roberts, Paul Burrowes, Daria Manos, Lori Stewart, Jean M. Seely, Michel Gingras, Sergio Pasian, Ming-Sound Tsao, Stephen Lam and Don D. Sin, for the Pan-Canadian Early Lung Cancer Study Group. Eur Respir J 2015; 45: 1037–1045.. “Plasma pro-surfactant protein B and lung function decline in smokers.”. Eur Respir J 2016; 48: 962

Member's Comments

No comment yet.

Related content which might interest you: Plasma pro-surfactant protein B and lung function decline in smokers Source: Eur Respir J 2015; 45: 1037-1045 Year: 2015 Plasma markers of oxidative protein damage do not correlate with lung function or COPD in smokers Source: Eur Respir J 2006; 28: Suppl. 50, 144s Year: 2006 Serum surfactant protein D (SPD) as a specific marker for COPD Source: Annual Congress 2012 - COPD treatment and varia Year: 2012 Elevated C-reactive protein is associated with reduced lung function and exercise capacity in normal subjects. Are we born inflammed? Source: Eur Respir J 2006; 28: Suppl. 50, 331s Year: 2006 Plasma surfactant protein D (SP-D) and nutritive status in patients with COPD Source: Annual Congress 2013 –COPD treatment and others Year: 2013 Serum surfactant protein D (SP-D) is a lung derived biomarker for COPD that is responsive to treatment with oral corticosteroids Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008 Rapid decline in lung function in COPD is associated with decreased CD25brightFoxP3 regulatory T cells in BAL Source: International Congress 2019 – COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses Year: 2019 Serum endostatin is a novel marker for COPD associated to lung function decline and exacerbation Source: International Congress 2019 – Evaluation of basic science in airway diseases Year: 2019 High-sensitive C-reactive protein is associated with reduced lung function in young adults Source: Eur Respir J 2009; 33: 382-388 Year: 2009 Lipid metabolite levels recovered from BAL fluid correlate with lung function of COPD patients and controls Source: Annual Congress 2008 - Novel trends in functional genomics and molecular pathology of neoplastic and non-neoplastic lung diseases Year: 2008 Elevation of plasma cystatin C levels in patients with COPD Source: Eur Respir J 2002; 20: Suppl. 38, 583s Year: 2002 Relationship between plasma amino acid levels and lung function decline in patients with COPD Source: Annual Congress 2013 –COPD: markers and inflammation Year: 2013 The effect of MRP1 variants and the intensity of MRP1 protein expression in bronchial biopsies on lung function decline in COPD Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD Year: 2010 Leptin levels are associated with reduced lung function in men with COPD Source: Virtual Congress 2021 – COPD burden, epidemiology and management Year: 2021 Sputum Vitamin D binding protein (VDBP) GC1S/1S genotype predicts airway obstruction: a prospective study in smokers with COPD Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases Year: 2020 Association between serum levels of clara cell secretory protein and lung function in adults from ECRHS Source: Annual Congress 2012 - COPD: risk factors, biomarkers and diagnosis Year: 2012 Interleukin-10 expressing regulatory B cells are decreased in blood of smokers and COPD patients Source: Virtual Congress 2021 – New insight into the immunology of allergies, asthma and COPD: from mouse to man Year: 2021 Loss of plasma phospholipid transfer protein (PLTP) activity enhances inflammatory responses to cigarette smoke in the lung Source: Annual Congress 2013 –Acute lung injury: novel clinical and experimental insights Year: 2013 Plasma levels of soluble RAGE are lower in COPD Source: Annual Congress 2009 - COPD and asthma - from the cell to the clinic Year: 2009 Analysis of Immunoglobulin A and M gene expression and plasma cells in bronchial tissue from COPD patients with high blood eosinophil counts Source: International Congress 2018 – Advanced profiling of immune cells in chronic lung diseases Year: 2018